CleopATTRa - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults
Study Details
Full Title
CLEOPATTRA: Effects of NNC6019-0001 versus placebo on cardiovascular outcomes in participants with transthyretin amyloid cardiomyopathy (ATTR-CM)
Principal Investigator
Michel G. Khouri, MD
Cardiologist
Protocol Number
IRB:
PRO00118780
Phase
Phase III
Enrollment Status
Open for Enrollment